These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25887468)

  • 1. Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.
    Pal AR; Langereis EJ; Saif MA; Mercer J; Church HJ; Tylee KL; Wynn RF; Wijburg FA; Jones SA; Bruce IA; Bigger BW
    Orphanet J Rare Dis; 2015 Apr; 10():42. PubMed ID: 25887468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.
    Langereis EJ; van Vlies N; Church HJ; Geskus RB; Hollak CE; Jones SA; Kulik W; van Lenthe H; Mercer J; Schreider L; Tylee KL; Wagemans T; Wijburg FA; Bigger BW
    Mol Genet Metab; 2015 Feb; 114(2):129-37. PubMed ID: 25467058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I.
    Moreau J; Brassier A; Amaddeo A; Neven B; Caillaud C; Chabli A; Fernandez-Bolanos M; Olmo J; Valayannopoulos V; Fauroux B
    Mol Genet Metab; 2015 Dec; 116(4):275-80. PubMed ID: 26602600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open issues in Mucopolysaccharidosis type I-Hurler.
    Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
    Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I.
    Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S
    Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative complications in patients diagnosed with mucopolysaccharidosis and the impact of enzyme replacement therapy followed by hematopoietic stem cell transplantation at early age.
    Megens JH; de Wit M; van Hasselt PM; Boelens JJ; van der Werff DB; de Graaff JC
    Paediatr Anaesth; 2014 May; 24(5):521-7. PubMed ID: 24612129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management.
    Kirkpatrick K; Ellwood J; Walker RW
    Paediatr Anaesth; 2012 Aug; 22(8):745-51. PubMed ID: 22672476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.
    de Ru MH; Boelens JJ; Das AM; Jones SA; van der Lee JH; Mahlaoui N; Mengel E; Offringa M; O'Meara A; Parini R; Rovelli A; Sykora KW; Valayannopoulos V; Vellodi A; Wynn RF; Wijburg FA
    Orphanet J Rare Dis; 2011 Aug; 6():55. PubMed ID: 21831279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.
    Yamazaki N; Kosuga M; Kida K; Takei G; Fukuhara Y; Matsumoto H; Senda M; Honda A; Ishiguro A; Koike T; Yabe H; Okuyama T
    Brain Dev; 2019 Jun; 41(6):546-550. PubMed ID: 30755342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II.
    Wang RY; Cambray-Forker EJ; Ohanian K; Karlin DS; Covault KK; Schwartz PH; Abdenur JE
    Mol Genet Metab; 2009 Dec; 98(4):406-11. PubMed ID: 19748810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses.
    Jones SA; Marsden D; Koutsoukos T; Sniadecki J; Tylee K; Phillippo S; Kakkis E
    Mol Genet Metab; 2020 Aug; 130(4):255-261. PubMed ID: 32563631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterisation of pulmonary function in patients with mucopolysaccharidoses IVA: A longitudinal analysis.
    Kenth JJ; Thompson G; Fullwood C; Wilkinson S; Jones S; Bruce IA
    Mol Genet Metab Rep; 2019 Sep; 20():100487. PubMed ID: 31341787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of sleep-disordered breathing and its relationship with respiratory parameters in children with mucopolysaccharidosis Type IVA and VI.
    Ademhan Tural D; Emiralioglu N; Dogru D; Ozsezen B; Ipek OF; Sunman B; Nayir Buyuksahin H; Guzelkas I; Ciki K; Kilic K; Vardar Yagli N; Yalcin E; Kiper N; Sivri S; Ozcelik U
    Am J Med Genet A; 2021 Aug; 185(8):2306-2314. PubMed ID: 33960649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.
    de Ru MH; van der Tol L; van Vlies N; Bigger BW; Hollak CE; Ijlst L; Kulik W; van Lenthe H; Saif MA; Wagemans T; van der Wal WM; Wanders RJ; Wijburg FA
    J Inherit Metab Dis; 2013 Mar; 36(2):247-55. PubMed ID: 22991166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.
    Cox-Brinkman J; Boelens JJ; Wraith JE; O'meara A; Veys P; Wijburg FA; Wulffraat N; Wynn RF
    Bone Marrow Transplant; 2006 Jul; 38(1):17-21. PubMed ID: 16715104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
    Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
    Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler.
    Ferrara G; Maximova N; Zennaro F; Gregori M; Tamaro P
    Pediatr Transplant; 2014 May; 18(3):E96-9. PubMed ID: 24483599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses.
    Frawley G; Fuenzalida D; Donath S; Yaplito-Lee J; Peters H
    Paediatr Anaesth; 2012 Aug; 22(8):737-44. PubMed ID: 22381044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.
    Kuiper GA; van Hasselt PM; Boelens JJ; Wijburg FA; Langereis EJ
    Mol Genet Metab; 2017 Sep; 122(1-2):86-91. PubMed ID: 28684085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.